Literature DB >> 27273168

The role of the gut microbiota in NAFLD.

Christopher Leung1,2, Leni Rivera3,4, John B Furness4, Peter W Angus1,2.   

Abstract

NAFLD is now the most common cause of liver disease in Western countries. This Review explores the links between NAFLD, the metabolic syndrome, dysbiosis, poor diet and gut health. Animal studies in which the gut microbiota are manipulated, and observational studies in patients with NAFLD, have provided considerable evidence that dysbiosis contributes to the pathogenesis of NAFLD. Dysbiosis increases gut permeability to bacterial products and increases hepatic exposure to injurious substances that increase hepatic inflammation and fibrosis. Dysbiosis, combined with poor diet, also changes luminal metabolism of food substrates, such as increased production of certain short-chain fatty acids and alcohol, and depletion of choline. Changes to the microbiome can also cause dysmotility, gut inflammation and other immunological changes in the gut that might contribute to liver injury. Evidence also suggests that certain food components and lifestyle factors, which are known to influence the severity of NAFLD, do so at least in part by changing the gut microbiota. Improved methods of analysis of the gut microbiome, and greater understanding of interactions between dysbiosis, diet, environmental factors and their effects on the gut-liver axis should improve the treatment of this common liver disease and its associated disorders.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27273168     DOI: 10.1038/nrgastro.2016.85

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  188 in total

1.  Temporal pattern of de novo lipogenesis in the postprandial state in healthy men.

Authors:  Maureen T Timlin; Elizabeth J Parks
Journal:  Am J Clin Nutr       Date:  2005-01       Impact factor: 7.045

2.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.

Authors:  Yukihiro Furusawa; Yuuki Obata; Shinji Fukuda; Takaho A Endo; Gaku Nakato; Daisuke Takahashi; Yumiko Nakanishi; Chikako Uetake; Keiko Kato; Tamotsu Kato; Masumi Takahashi; Noriko N Fukuda; Shinnosuke Murakami; Eiji Miyauchi; Shingo Hino; Koji Atarashi; Satoshi Onawa; Yumiko Fujimura; Trevor Lockett; Julie M Clarke; David L Topping; Masaru Tomita; Shohei Hori; Osamu Ohara; Tatsuya Morita; Haruhiko Koseki; Jun Kikuchi; Kenya Honda; Koji Hase; Hiroshi Ohno
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

3.  Overstated associations between fructose and nonalcoholic fatty liver disease.

Authors:  Laura Chiavaroli; Vanessa Ha; Russell J de Souza; Cyril W C Kendall; John L Sievenpiper
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-04       Impact factor: 2.839

4.  Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice.

Authors:  Marc-Emmanuel Dumas; Richard H Barton; Ayo Toye; Olivier Cloarec; Christine Blancher; Alice Rothwell; Jane Fearnside; Roger Tatoud; Véronique Blanc; John C Lindon; Steve C Mitchell; Elaine Holmes; Mark I McCarthy; James Scott; Dominique Gauguier; Jeremy K Nicholson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-08       Impact factor: 11.205

5.  Artificial sweeteners produce the counterintuitive effect of inducing metabolic derangements.

Authors:  Susan E Swithers
Journal:  Trends Endocrinol Metab       Date:  2013-07-10       Impact factor: 12.015

6.  Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats.

Authors:  Ece Mutlu; Ali Keshavarzian; Phillip Engen; Christopher B Forsyth; Masoumeh Sikaroodi; Patrick Gillevet
Journal:  Alcohol Clin Exp Res       Date:  2009-07-23       Impact factor: 3.455

7.  Influence of coffee (Coffea arabica) and galacto-oligosaccharide consumption on intestinal microbiota and the host responses.

Authors:  Tatsuya Nakayama; Kazunori Oishi
Journal:  FEMS Microbiol Lett       Date:  2013-05-09       Impact factor: 2.742

8.  Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis.

Authors:  Jianye Yuan; Susan S Baker; Wensheng Liu; Razan Alkhouri; Robert D Baker; Jianqun Xie; Guang Ji; Lixin Zhu
Journal:  J Gastroenterol Hepatol       Date:  2014-06       Impact factor: 4.029

9.  Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.

Authors:  Wonhee Hur; Joon Ho Lee; Sung Woo Kim; Jung-Hee Kim; Si Hyun Bae; Minhyung Kim; Daehee Hwang; Young Seok Kim; Taesun Park; Soo-Jong Um; Byoung-Joon Song; Seung Kew Yoon
Journal:  Int J Biochem Cell Biol       Date:  2015-05-07       Impact factor: 5.085

Review 10.  Kingdom-agnostic metagenomics and the importance of complete characterization of enteric microbial communities.

Authors:  Jason M Norman; Scott A Handley; Herbert W Virgin
Journal:  Gastroenterology       Date:  2014-02-05       Impact factor: 22.682

View more
  225 in total

Review 1.  Functional Microbiomics in Liver Transplantation: Identifying Novel Targets for Improving Allograft Outcomes.

Authors:  Michael Kriss; Elizabeth C Verna; Hugo R Rosen; Catherine A Lozupone
Journal:  Transplantation       Date:  2019-04       Impact factor: 4.939

2.  Small intestinal bacterial overgrowth (SIBO) and vitamin K-responsive coagulopathy: a previously unrecorded association.

Authors:  Ricardo Brandt Oliveira; Ana Lourdes Candolo Martinelli; Luiz Ernesto Almeida Troncon; Jorge Elias
Journal:  BMJ Case Rep       Date:  2018-06-06

Review 3.  Current State of Knowledge on Implications of Gut Microbiome for Surgical Conditions.

Authors:  Edmund B Chen; Cori Cason; Jack A Gilbert; Karen J Ho
Journal:  J Gastrointest Surg       Date:  2018-04-05       Impact factor: 3.452

Review 4.  Microbial modulation of cardiovascular disease.

Authors:  J Mark Brown; Stanley L Hazen
Journal:  Nat Rev Microbiol       Date:  2018-01-08       Impact factor: 60.633

5.  Bile acid sequestration reverses liver injury and prevents progression of nonalcoholic steatohepatitis in Western diet-fed mice.

Authors:  Shogo Takahashi; Yuhuan Luo; Suman Ranjit; Cen Xie; Andrew E Libby; David J Orlicky; Alexander Dvornikov; Xiaoxin X Wang; Komuraiah Myakala; Bryce A Jones; Kanchan Bhasin; Dong Wang; James L McManaman; Kristopher W Krausz; Enrico Gratton; Diana Ir; Charles E Robertson; Daniel N Frank; Frank J Gonzalez; Moshe Levi
Journal:  J Biol Chem       Date:  2020-02-19       Impact factor: 5.157

Review 6.  Role and effective therapeutic target of gut microbiota in NAFLD/NASH.

Authors:  Qun Liu; Shousheng Liu; Lizhen Chen; Zhenzhen Zhao; Shuixian Du; Quanjiang Dong; Yongning Xin; Shiying Xuan
Journal:  Exp Ther Med       Date:  2019-07-17       Impact factor: 2.447

Review 7.  Epidemiology of Pediatric Nonalcoholic Fatty Liver Disease.

Authors:  Elizabeth L Yu; Jeffrey B Schwimmer
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

Review 8.  Chemical signaling between gut microbiota and host chromatin: What is your gut really saying?

Authors:  Kimberly A Krautkramer; Federico E Rey; John M Denu
Journal:  J Biol Chem       Date:  2017-04-07       Impact factor: 5.157

9.  Targeting the gut barrier for the treatment of alcoholic liver disease.

Authors:  Zhanxiang Zhou; Wei Zhong
Journal:  Liver Res       Date:  2017-12

Review 10.  Circadian Rhythms in the Pathogenesis and Treatment of Fatty Liver Disease.

Authors:  Anand R Saran; Shravan Dave; Amir Zarrinpar
Journal:  Gastroenterology       Date:  2020-02-13       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.